Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Alembic Pharmaceuticals | Modafinil | Modafinil |  | 2012-10-18 |  |  |
Allergan | Modafinil | Modafinil |  | 2012-11-01 |  |  |
Apotex | Modafinil | Modafinil |  | 2014-02-03 |  |  |
Appco Pharma | Modafinil | Modafinil |  | 2017-08-16 |  |  |
Atnahs Pharmaceuticals | Solriamfetol | Sunosi |  | 2020-01-16 |  |  |
Aurobindo Pharma | Modafinil | Modafinil |  | 2012-09-27 |  |  |
Bioprojet | Pitolisant | Ozawade |  | 2021-09-01 |  |  |
Cephalon | Modafinil | Provigil | 2023-11-29 | 1998-12-24 | $535.976 M | Q2/10-Q2/11 |
GSK | Umeclidinium, Fluticasone furoate, Vilanterol | Elebrato Ellipta |  | 2017-11-15 |  |  |
Fluticasone furoate, Vilanterol | Relvar Ellipta |  | 2013-11-13 |  |  | |
Fluticasone furoate, Vilanterol | Revinty Ellipta |  | 2014-05-02 |  |  | |
Umeclidinium, Fluticasone furoate, Vilanterol | Temybric Ellipta |  | 2019-06-12 |  |  | |
Umeclidinium, Fluticasone furoate, Vilanterol | Trelegy Ellipta |  | 2017-11-15 |  |  | |
Hikma Pharmaceuticals | Modafinil | Modafinil |  | 2012-09-26 |  |  |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|